Director sold ~$267K of Jazz Pharmaceuticals
Scheduled in advanceLoading…
Traded May 22, 2026 · Filed May 28, 2026
A board member of Jazz Pharmaceuticals sold $482K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$482,000
Shares × reported transaction price
17 days after results of May 5, 2026, 73 days before results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.0% | +0.3% | +1.7% |
| 30 days | +1.0% | −1.8% | +2.8% |
| 90 days | +5.9% | +1.5% | +4.4% |
Past results only. Not a forecast.
Director sold ~$267K of Jazz Pharmaceuticals
Scheduled in advanceOfficer sold ~$278K of Jazz Pharmaceuticals
Scheduled in advanceGift or transfer — classified separately from trades.